Epax® NovusLipid

Beyond Omega-3: EPAX® Cetoleic 10

EPAX® Cetoleic 10 contains both cetoleic acid – an Omega-11 marine lipid – and gondoic acid (Omega-9). Rich in long-chain monounsaturated fatty acids (LC-MUFAs), new Epax research indicates that it may have particular benefits for skin health.

In a double-blind, placebo-controlled, randomized pilot trial, skin redness was significantly reduced in subjects taking EPAX® Cetoleic 10¹. And although it contains less EPA and DHA than typical Omega-3 products, another study has found that it can boost the Omega-3 index².

Previous studies on animals have also indicated that fish oils rich in cetoleic acid can reduce inflammation and atherosclerosis, and help prevent the development of metabolic syndrome^3,4.

All EPAX® oils are produced to the highest quality standards, in a facility approved by US FDA for manufacture of Pharmaceutical Intermediates and approved by the Norwegian Medicines Agency for manufacture of Active Pharmaceutical Ingredients (API).

^{1. Mildenberger J. and Midtbø LK. Optihud: A nutritional, single centre, placebo controlled, randomised, blinded study of the effect of mackerel oil on skin quality and omega-3 index. Internal report 2022.}

^{2. Midtbø LK and Mildenberger J. CetoIndex. A nutritional, single centre, placebo controlled, randomised, blinded study of the effect of different fish oils on omega-3 index. Internal report 2022.}

^{3. Yang ZH, Emma-Okon B, Remaley AT. Dietary marine-derived long-chain monounsaturated fatty acids and cardiovascular disease risk: a mini review. Lipids Health Dis. Nov 22 2016;15(1):201.}

^{4. Yang ZH, Miyahara H, Mori T, Doisaki N, Hatanaka A. Beneficial effects of dietary ­fish-oil-derived monounsaturated fatty acids on metabolic syndrome risk factors and insulin resistance in mice. J Agric Food Chem. Jul 13 2011;59(13):7482-9.}